About 90% of the active ingredients used by US companies in drug manufacturing come from China. That’s been the case for a number of years, but the coronavirus outbreak has put that dependence under scrutiny. Congress is now taking up the issue as pharmacies and hospitals brace for shortages because of disrupted production in China. Marco Werman talks with Rosemary Gibson, author of “China RX: Exposing the Risks of America’s Dependence on China for Medicine.”
The story you just read is available for free because thousands of listeners and readers like you generously support our nonprofit newsroom. Every day, reporters and producers at The World are hard at work bringing you human-centered news from across the globe. But we can’t do it without you: We need your support to ensure we can continue this work for another year.
Make a gift today, and you’ll get us one step closer to our goal of raising $25,000 by June 14. We need your help now more than ever!